Minimally invasive therapies for cancer treatment
Official title: Interventional oncology clinical research specialist
Funded at University of Pennsylvania · NIH-11077233 · Data updated 2026-11-12
This study is exploring new, less invasive ways to treat cancer that are easier on the body than traditional methods, and it's designed for patients who want better treatment options and outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | May 1, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $173,119 |
| NIH project number | 5R50CA276008-03 |
| Project ID | NIH-11077233 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are cancer patients who are seeking alternative treatment options to traditional therapies.
✕Less likely to help
Patients with advanced cancer stages that are not amenable to minimally invasive procedures may not benefit from this research.
What this research studies
This research focuses on advancing interventional oncology, which uses minimally invasive, image-guided techniques to treat cancer without the harsh side effects associated with traditional therapies like chemotherapy and radiation. The project aims to develop new clinical trial designs that integrate these innovative therapies into comprehensive cancer care plans. By fostering collaborations among various oncology specialties, the research seeks to overcome existing barriers in clinical trial recruitment and execution, ultimately improving patient outcomes. The goal is to establish effective protocols that can be widely adopted in cancer treatment.
Why it matters
Potential benefit: If successful, this research could provide cancer patients with safer and more effective treatment options that minimize side effects.
How similar studies have gone: Other research in interventional oncology has shown promise, indicating that this approach could lead to significant advancements in cancer treatment.
Where this research is happening
-
University of Pennsylvania
Philadelphia, United States Active
Researchers
- Principal investigator: Soulen, Michael C — University of Pennsylvania
- Study coordinator: Soulen, Michael C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.